Clinical Trials Browser

Dementia, Kidney Diseases, Lung Diseases, Obstructive, Neoplasms

NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Phase 3 Recruiting

420 enrolled

Lymphoid

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

NCT05522387 2026-02-27

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Phase 2 Terminated

11 enrolled

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Phase 4 Active not recruiting

100 enrolled

Genitourinary

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT05894954 2026-02-18

EVANTHEA

Phase 3 Completed

73 enrolled

Lymphoid

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06125951 2026-02-18

XanaMIA

Phase 2/3 Active not recruiting

247 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular

Clinical Trials

PATH

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

EVANTHEA

XanaMIA